Prognostic impact of JAK2V617F mutation in myelodysplatic syndromes: A matched case control study
{{output}}
While in RARS-T, JAK2V617F mutation is common and associated with good prognosis, the clinical and prognostic impact of this mutation in other MDS is unknown. We collected data from 132 non-RARS-T MDS with known JAK2V617F mutation status. JAK2V617F mutation wa... ...
